These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24709412)

  • 1. Thoroughfares, crossroads and cul-de-sacs: drug testing of welfare recipients.
    Wincup E
    Int J Drug Policy; 2014 Sep; 25(5):1031-7. PubMed ID: 24709412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
    Monaghan M; Wincup E
    Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partnerships and communities in English drug policy: the challenge of deprivation.
    Macgregor S; Thickett A
    Int J Drug Policy; 2011 Nov; 22(6):478-90. PubMed ID: 21890338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sameness and difference: metaphor and politics in the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy.
    Moore D; Fraser S; Törrönen J; Tinghög ME
    Int J Drug Policy; 2015 Apr; 26(4):420-8. PubMed ID: 25662895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthesis of welfare reform policy and its impact on substance users.
    Montoya ID; Atkinson JS
    Am J Drug Alcohol Abuse; 2002; 28(1):133-46. PubMed ID: 11853129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV testing for HIV prevention: a comparative analysis of policies in Britain, Hungary and Sweden.
    Danziger R
    AIDS Care; 1998 Oct; 10(5):563-70. PubMed ID: 9828953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social rights and employment rights related to family care: family care regimes in Europe.
    Frericks P; Jensen PH; Pfau-Effinger B
    J Aging Stud; 2014 Apr; 29():66-77. PubMed ID: 24655674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An all-embracing problem description. The Swedish drug issue as a political catalyst 1982-2000.
    Edman J
    Int J Drug Policy; 2013 Nov; 24(6):558-65. PubMed ID: 23790617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Welfare reform and American Indians: critical issues for reauthorization.
    Scott W
    NHPF Issue Brief; 2002 Jun; (778):1-17. PubMed ID: 12096765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act.
    Monaghan M
    Int J Drug Policy; 2014 Sep; 25(5):1025-30. PubMed ID: 24635973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse and welfare reform.
    Nakashian M
    J Am Med Womens Assoc (1972); 2002; 57(1):36-7, 40. PubMed ID: 11905489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overhauling welfare: implications for reproductive health policy in the United States.
    Boonstra H; Gold RB
    J Am Med Womens Assoc (1972); 2002; 57(1):41-6. PubMed ID: 11905491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative social policy and political conflict in advanced welfare states: Denmark and Sweden.
    Esping-Andersen G
    Int J Health Serv; 1979; 9(2):269-93. PubMed ID: 437936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is good governance in the context of drug policy?
    Singleton N; Rubin J
    Int J Drug Policy; 2014 Sep; 25(5):935-41. PubMed ID: 24768218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based policymaking is not like evidence-based medicine, so how far should you go to bridge the divide between evidence and policy?
    Cairney P; Oliver K
    Health Res Policy Syst; 2017 Apr; 15(1):35. PubMed ID: 28446185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The New Right and family politics.
    Somerville J
    Econ Soc; 1992 May; 21(2):93-128. PubMed ID: 12317778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Producing the 'problem of drugs': A cross national-comparison of 'recovery' discourse in two Australian and British reports.
    Lancaster K; Duke K; Ritter A
    Int J Drug Policy; 2015 Jul; 26(7):617-25. PubMed ID: 25962733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.